These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 10171013

  • 41. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul 24; 63(142):39789-90. PubMed ID: 10181516
    [Abstract] [Full Text] [Related]

  • 42. Medical devices: classification of the dental sonography device and jaw tracking device. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 02; 68(231):67365-7. PubMed ID: 14651050
    [Abstract] [Full Text] [Related]

  • 43. Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Jul 31; 63(147):40825. PubMed ID: 10181716
    [Abstract] [Full Text] [Related]

  • 44. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May 14; 64(93):26282-7. PubMed ID: 10558530
    [Abstract] [Full Text] [Related]

  • 45. Medical devices; obstetrical and gynecological devices; classification of the breast lesion documentation system. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jul 28; 68(144):44413-5. PubMed ID: 12884877
    [Abstract] [Full Text] [Related]

  • 46. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Sep 22; 63(183):50660-704. PubMed ID: 10185803
    [Abstract] [Full Text] [Related]

  • 47. Medical devices: cardiovascular devices: reclassification of the arrhythmia detector and alarm. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Oct 28; 68(208):61342-4. PubMed ID: 14584507
    [Abstract] [Full Text] [Related]

  • 48. Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Jun 16; 63(115):32772-4. PubMed ID: 10180279
    [Abstract] [Full Text] [Related]

  • 49. Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1997 Dec 23; 62(246):67011-3. PubMed ID: 10179309
    [Abstract] [Full Text] [Related]

  • 50. Medical devices; reclassification of the cutaneous carbon dioxide and the cutaneous oxygen monitor. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Dec 13; 67(240):76678-81. PubMed ID: 12481766
    [Abstract] [Full Text] [Related]

  • 51. Facilities strive to comply with new Act. The long-term effects of the Safe Medical Devices Act are still unknown.
    Schuster DK, Butler KH.
    Health Prog; 1993 May 13; 74(4):53-7. PubMed ID: 10125364
    [Abstract] [Full Text] [Related]

  • 52. Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability date.
    Food and Drug Administration, HHS.
    Fed Regist; 2006 Nov 13; 71(218):66108-9. PubMed ID: 17099971
    [Abstract] [Full Text] [Related]

  • 53. Medical devices; clinical chemistry and clinical toxicology devices; classification of the breath nitric oxide test system. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jul 07; 68(129):40125-7. PubMed ID: 12858842
    [Abstract] [Full Text] [Related]

  • 54. Medical devices; apnea monitor; special controls. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Jul 17; 67(137):46851-2. PubMed ID: 12125715
    [Abstract] [Full Text] [Related]

  • 55. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov 12; 63(218):63222-53. PubMed ID: 10187398
    [Abstract] [Full Text] [Related]

  • 56. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov 20; 63(224):64556-88. PubMed ID: 10339052
    [Abstract] [Full Text] [Related]

  • 57. Order for transitional class III devices; submission of safety and effectiveness information under section 520(1)(5)(A) of the Federal Food, Drug, and Cosmetic Act--FDA. Notice.
    Fed Regist; 1991 Nov 14; 56(220):57960-3. PubMed ID: 10115560
    [Abstract] [Full Text] [Related]

  • 58. Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Aug 19; 64(160):45366-74. PubMed ID: 10558597
    [Abstract] [Full Text] [Related]

  • 59. Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 May 11; 69(91):26036-8. PubMed ID: 15137395
    [Abstract] [Full Text] [Related]

  • 60. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec 12; 65(239):77497-9. PubMed ID: 11503726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.